Purchases and Sales Made in Q3 2022 in Allarity Therapeutics, Inc. (ALLR)
This table provides information about the institutional ownership of Allarity Therapeutics, Inc. (ALLR) during Q3 2022. The information is specifically focused on institutions that hold shares of Allarity Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
16.1KNew |
$16.8K - $552M
|
16.1K
$17K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
11.9K+ 581.96% |
$12.4K - $407M
|
13.9K
$14.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 7.84% |
$4.16 - $137K
|
55
$57.8
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
3+ 2.03% |
$3.12 - $102K
|
151
$159
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-61.1K- 70.72% |
$63.5K - $2.09B
|
25.3K
$26.6K
|